Testing a special filter to clean blood in shock and kidney failure
Part of Infections clinical trials.
This trial is testing a special blood filter (oXiris) to see if it helps remove harmful substances from the blood of people in the intensive care unit with shock and kidney failure. It may help improve blood pressure and reduce the need for strong medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in the intensive care unit with a type of shock that needs a medicine called noradrenaline to support your blood pressure.
- You are at least 6 years old and weigh at least 30 kilograms (about 66 pounds).
- You need a blood cleaning treatment called hemofiltration for kidney failure, fluid overload, severe acidosis, or electrolyte imbalance.
- Your doctor decides to use a special filter called oXiris for this blood cleaning.
- You are not using a specific blood thinner called citrate in the hemofiltration circuit.
- You are not currently in another interventional research study (category 1 or 2).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special blood filter called Oxiris that may help remove toxins and inflammation from the blood in patients with septic shock. It aims to see if this treatment can improve outcomes for people who need kidney replacement therapy.
This trial tests whether a special type of dialysis filter (oXiris) helps reduce blood clotting problems in patients with septic shock and kidney failure. It may offer a better option for those needing kidney support in the ICU.
This study tests a special blood filter (Oxiris) to see if it helps clean the blood in people with septic shock. If you are receiving blood purification therapy, this filter might help your body recover better.
This study looks back at how a special kidney filter called oXiris helped patients in the ICU who had septic shock (a life-threatening blood infection) and kidney failure. Researchers want to understand if this filter improved survival and recovery compared to standard treatment.
This trial tests a special blood-filtering device (OXiris) for people with severe abdominal infections that cause septic shock and kidney damage. It aims to see if this treatment can help control the infection and improve recovery.
This study looks at an add-on blood-filter treatment used in the ICU to help remove harmful substances like waste products, inflammation signals, or toxins from the blood. Results may help doctors understand whether this approach improves care and how it should be used.
Hear when a new Critically Ill Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.